Virginia K. Sutton

2.5k total citations
35 papers, 1.7k citations indexed

About

Virginia K. Sutton is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Virginia K. Sutton has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 6 papers in Cognitive Neuroscience. Recurrent topics in Virginia K. Sutton's work include Attention Deficit Hyperactivity Disorder (14 papers), Schizophrenia research and treatment (10 papers) and Electroconvulsive Therapy Studies (8 papers). Virginia K. Sutton is often cited by papers focused on Attention Deficit Hyperactivity Disorder (14 papers), Schizophrenia research and treatment (10 papers) and Electroconvulsive Therapy Studies (8 papers). Virginia K. Sutton collaborates with scholars based in United States, Singapore and United Kingdom. Virginia K. Sutton's co-authors include Douglas K. Kelsey, Albert J. Allen, Calvin R. Sumner, Kory Schuh, Alan Breier, R. Bart Sangal, Pádraig Wright, Jeffrey H. Newcorn, Cindy C. Taylor and Keith E. Saylor and has published in prestigious journals such as PEDIATRICS, Biological Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Virginia K. Sutton

35 papers receiving 1.6k citations

Peers

Virginia K. Sutton

PMH

ECP

PHARM

Rosa Ayesa‐Arriola Spain

Mário R. Louzã Brazil

Merete Glenne Øie Norway

Jan‐Otto Ottosson Sweden

Petter Andreas Ringen Norway

Jeffrey Sverd United States

Carmen Simonsen Norway

Lawrence Maayan United States

Anne Halmøy Norway

John Abel Engh Norway

Rosa Ayesa‐Arriola Spain

Virginia K. Sutton

1.3k ×1.0

PMH

440 ×1.0

456 ×1.1

235 ×0.9

ECP

186 ×1.0

PHARM

Citations per year, relative to Virginia K. Sutton Virginia K. Sutton (= 1×) peers Rosa Ayesa‐Arriola

Countries citing papers authored by Virginia K. Sutton

Since Specialization

Citations

This map shows the geographic impact of Virginia K. Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia K. Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia K. Sutton more than expected).

Fields of papers citing papers by Virginia K. Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia K. Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia K. Sutton. The network helps show where Virginia K. Sutton may publish in the future.

Co-authorship network of co-authors of Virginia K. Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia K. Sutton. A scholar is included among the top collaborators of Virginia K. Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia K. Sutton. Virginia K. Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newcorn, Jeffrey H., Virginia K. Sutton, Shuyu Zhang, et al.. (2009). Characteristics of Placebo Responders in Pediatric Clinical Trials of Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 48(12). 1165–1172. 34 indexed citations

Newcorn, Jeffrey H., Virginia K. Sutton, Margaret D. Weiss, & Calvin R. Sumner. (2009). Clinical Responses to Atomoxetine in Attention-Deficit/Hyperactivity Disorder: The Integrated Data Exploratory Analysis (IDEA) Study. Journal of the American Academy of Child & Adolescent Psychiatry. 48(5). 511–518. 72 indexed citations

Tohen, Mauricio, et al.. (2009). Number Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of Bipolar Disorder. Journal of Clinical Psychopharmacology. 29(6). 520–528. 5 indexed citations

Perlis, Roy H., David Adams, Bonnie A. Fijal, et al.. (2009). Genetic Association Study of Treatment Response With Olanzapine/Fluoxetine Combination or Lamotrigine in Bipolar I Depression. The Journal of Clinical Psychiatry. 71(5). 599–605. 33 indexed citations

Sutton, Virginia K., et al.. (2009). Effectiveness and Safety of the Combination of Fluoxetine and Olanzapine in Outpatients With Bipolar Depression. Journal of Clinical Psychopharmacology. 29(4). 358–361. 24 indexed citations

Owens, Judith, et al.. (2008). Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder. Sleep Medicine. 10(4). 446–456. 113 indexed citations

Perlis, Roy H., Bonnie A. Fijal, David H. Adams, et al.. (2008). Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder. Biological Psychiatry. 65(9). 785–791. 64 indexed citations

Tohen, Mauricio, Virginia K. Sutton, Joseph R. Calabrese, Roy H. Perlis, & Charles L. Bowden. (2008). Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. Journal of Affective Disorders. 116(1-2). 43–50. 37 indexed citations

Saylor, Keith E., et al.. (2007). The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder–Child Version: Psychometric Properties of an Adaptive Change Instrument. Journal of Child and Adolescent Psychopharmacology. 17(6). 831–842. 16 indexed citations

10.

Geller, Daniel, Craig L. Donnelly, Frank A. López, et al.. (2007). Atomoxetine Treatment for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 46(9). 1119–1127. 145 indexed citations

11.

Sangal, R. Bart, Judith Owens, Albert J. Allen, et al.. (2006). Effects of Atomoxetine and Methylphenidate on Sleep in Children With ADHD. SLEEP. 29(12). 1573–1585. 150 indexed citations

12.

Beasley, Charles M., Virginia K. Sutton, Cindy C. Taylor, et al.. (2006). Is Quality of Life Among Minimally Symptomatic Patients With Schizophrenia Better Following Withdrawal or Continuation of Antipsychotic Treatment?. Journal of Clinical Psychopharmacology. 26(1). 40–44. 12 indexed citations

13.

Sumner, Calvin R., Kory Schuh, Virginia K. Sutton, Robert Lipetz, & Douglas K. Kelsey. (2006). Placebo-Controlled Study of the Effects of Atomoxetine on Bladder Control in Children With Nocturnal Enuresis. Journal of Child and Adolescent Psychopharmacology. 16(6). 699–711. 41 indexed citations

14.

Adler, Lenard A., Virginia K. Sutton, Rodney J. Moore, et al.. (2006). Quality of Life Assessment in Adult Patients With Attention-deficit/Hyperactivity Disorder Treated With Atomoxetine. Journal of Clinical Psychopharmacology. 26(6). 648–652. 48 indexed citations

15.

Feldman, Peter D., Christopher Kaiser, John Kennedy, et al.. (2003). Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years. The Journal of Clinical Psychiatry. 64(9). 998–1004. 26 indexed citations

16.

Beasley, Charles M., Virginia K. Sutton, S.H. Hamilton, et al.. (2003). A Double-Blind, Randomized, Placebo-Controlled Trial of Olanzapine in the Prevention of Psychotic Relapse. Journal of Clinical Psychopharmacology. 23(6). 582–594. 76 indexed citations

17.

Allen, A.J., Douglas K. Kelsey, Calvin R. Sumner, et al.. (2003). P.6.068 Once-daily atomoxetine in childhood ADHD: Continuous symptom relief. European Neuropsychopharmacology. 13. S454–S455. 6 indexed citations

18.

Breier, Alan, et al.. (2002). Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s disease. Biological Psychiatry. 52(5). 438–445. 149 indexed citations

19.

Breier, Alan, Karena Meehan, Martin Birkett, et al.. (2002). A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia. Archives of General Psychiatry. 59(5). 441–441. 207 indexed citations

20.

Mintzer, Jacobo, Warachal Faison, J. Street, Virginia K. Sutton, & Alan Breier. (2001). Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. International Journal of Geriatric Psychiatry. 16(S1). S71–S77. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact